FowkesFGRudanDRudanI. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329–1340.
2.
HirschATCriquiMHTreat-JacobsonD. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–1324.
3.
CriquiMHFronekABarrett-ConnorE, The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510–515.
4.
FowkesFGHousleyECawoodEH. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20:384–392.
5.
MeijerWTHoesAWRutgersD. Peripheral arterial disease in the elderly: the Rotterdam study. Arterioscler Thromb Vasc Biol. 1998;18:185–192.
6.
HirschATAllisonMAGomesAS. A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2012;125:1449–1472.
7.
DeRubertisBGVouyoukaARheeSJ. Percutaneous intervention for infrainguinal occlusive disease in women: equivalent outcomes despite increased severity of disease compared with men. J Vasc Surg. 2008;48:150–157.
8.
OrtmannJNüeschETraupeT. Gender is an independent risk factor for distribution pattern and lesion morphology in chronic critical limb ischemia. J Vasc Surg. 2012;55:98–104.
9.
EgorovaNVouyoukaAGQuinJ. Analysis of gender-related differences in lower extremity peripheral arterial disease. J Vasc Surg. 2010;51:372–378.
10.
StavroulakisKDonasKPTorselloG. Gender-related long-term outcome of primary femoropopliteal stent placement for peripheral artery disease. J Endovasc Ther. 2015;22:31–37.
11.
PulliRDorigoWPratesiG. Gender-related outcomes in the endovascular treatment of infrainguinal arterial obstructive disease. J Vasc Surg. 2011;55:105–112.
12.
VouyoukaAGEgorovaNNSalloumA. Lessons learned from the analysis of gender effect on risk factors and procedural outcomes of lower extremity arterial disease. J Vasc Surg. 2010;52:1196–1202.
13.
TadrosROFariesPLRocha-SinghKJ. The impact of sex on angioplasty and primary stenting for femoropopliteal occlusive disease: results of the DURABILITY II trial. J Vasc Surg. 2014;28:1–9.
14.
McCoachCEArmstrongEJSinghS. Gender-related variation in the clinical presentation and outcomes of critical limb ischemia. Vasc Med. 2013;18:19–26.
15.
GallagherKAMeltzerAJRavinRA. Gender differences in outcomes of endovascular treatment of infrainguinal peripheral artery disease. Vasc Endovascular Surg. 2011;45:701–711.
16.
TyeAHanDKTadrosRO. Percutaneous intervention for infrageniculate arterial disease in women may be associated with better short-term outcomes when compared to men. J Vasc Surg. 2013;57:706–713.
17.
TandjungKBasalusMWSenH. Women treated with second-generation zotarolimus-eluting Resolute stents and everolimus-eluting Xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trial. Catheter Cardiovasc Interv. 2013;82:396–405.
18.
DakeMDAnselGMJaffMR. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4:495–504.
19.
DakeMDAnselGMJaffMR. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm trials. J Am Coll Cardiol. 2013;61:2417–2427.
